Community Dermatology Services for Lincolnshire East Clinical Commissioning Group.
NHS Arden and Greater East Midlands Commissioning Support Unit | Published July 21, 2015 - Deadline August 12, 2015
Lincolnshire East Clinical Commissioning Group are seeking to procure a Community Dermatology Service.
LECCG dermatology services are currently provided only from secondary care. The main current providers are United Lincolnshire Hospital Trust, and North Lincolnshire and Goole.
The service excludes two-week wait and Tier-four patients. All other patients aged six and over will be referred to the community dermatology service for assessment, diagnosis and treatment, within a shorter time frame.
The service is a proof of concept and will be frequently evaluated and developed to inform the future commissioning requirements for dermatology. The term of the contract is for 12-18 months.
It is expected that patients will be assessed and treated quickly, closer to home, and where possible within a One-Stop Shop see and treat model.
The service should enable the delivery of:
— Responsive and patient centred care
— High quality and safe care
— A standard and consistent dermatology service, available in the community, with equitable access
— A service within the principles of ‘no delays’ and a maximum 18 week referral to treatment standard
Referrals to dermatology services continue to rise, as a consequence of the increasingly ageing population, frequency of diseases such as skin cancer, and continued exposure to ultraviolet light.
The clinical scope of the proposed Consultant-delivered community dermatology service includes, but is not limited to:
— Inflammatory skin disease (acne, eczema, psoriasis) unresponsive to GP treatment
— Premalignant skin lesions such as solar keratosis or Bowen's disease
— Low risk BCCs on trunks and limbs in line with NICE guidance (including development of direct listing of BCCs for GPs)
— Mild to moderate non-scarring acne, un-responsive to routine treatment in primary care
— Acne requiring isotretinoin, where the prescribing will be the responsibility of the provider
— Diagnosis, investigation and management of other chronic rashes in adults,
— Diagnosis, investigation or management of mild-moderate/non-worrying dermatoses and skin lesions in children aged six and over
— Conditions of hair, scalp, and nails
— Management and advice, including follow-up, of skin cancer conditions treated in secondary care, by agreement with our current secondary care providers
— Assessment and advice for discrete skin lesions requiring diagnosis, including the development of teledermatology, through the ‘Proof of Concept’
The Provider must:
— Ensure that robust onward referral processes to secondary care are in place, in line with national clinical guidance and evidence-based best practice
— Up-skill referring GPs through guidance, education and feedback, including that provided by teledermatology
— Ensure that all appointments are made available via the NHS e-referral system
— Develop and build integrated care pathways
— Streamline the patient journey and the underpinning administrative pathways
— Collaborate with other NHS and Independent Sector providers to implement the new service model.
As a minimum, the service will be delivered from the following locations: Louth, Skegness and Boston,
In premises that are safe and suitable for the delivery of this service. The service will be community-based in locations across LECCG offering choice to patients in terms of location.
All of the above should be provided within the geographical boundaries of Lincolnshire East Clinical Commissioning Group.
Arden and Greater East Midlands Commissioning Support Unit acting on behalf of Lincolnshire East Clinical Commissioning Group (LECCG) invites expressions of interest from suitably qualified and experienced healthcare service providers including third sector organisations to provide a Community The CCG intends to let one contract for the service and would also encourage innovative solutions including consortia, strategic alliances and sub-contracts which will deliver value and improved services to patients.